Your CTO Should Never Own Your Patent Strategy

When the CTO owns IP, you get more patents, not better patents. And that is the opposite of what matters.


The most common pattern: the CEO delegates patent decisions to the CTO. The CTO talks to the patent attorney. It seems natural — the CTO understands the technology, speaks the attorney’s language, and cares about protecting the company’s innovations.

The results are predictable: poor-quality IP focused on the wrong inventions, open-loop spending with no budget discipline, and a patent portfolio that measures success by count instead of value.

This is not a CTO problem. It is a structural problem.

And it plays out the same way in nearly every company where technical leadership owns the patent function.


The CTO’s Wrong Incentives

One giant metric for the CTO is the sheer number of patents. Patent count looks like accomplishment. It appears on annual reports, investor decks, and board presentations. More patents means more innovation. More innovation means the CTO is doing their job.

But patent count is not a measure of patent value.

Twenty unenforceable patents are worth less than two that can actually be enforced. The CTO’s incentive — more filings, more certificates on the wall — runs directly opposite the company’s interest, which is fewer, better patents that change competitor behavior.

The CTO-attorney dynamic compounds the problem. The inventor feels like a prophet in the wilderness where nobody listens. The patent attorney does listen — and an undying allegiance forms. That allegiance gives the attorney free rein and an open license to consume the entire IP budget without oversight.

Open-loop operation: the inventor follows the attorney, and nobody watches the spend.5


Why Your Attorney Can’t Fill the Gap Either

The liability math facing every patent attorney is simple and devastating.2

If the attorney recommends filing and is wrong, the exposure is the cost of the patent — roughly $30,000. If the attorney recommends NOT filing and is wrong, the exposure is all of the client’s lost profits in every country for twenty years.

Any rational person facing that asymmetry will always recommend filing.

Always.

The structural result is that attorneys present options instead of making recommendations. The client came for advice. They got a menu. When the patent turns out to be worthless, the law firm shrugs: “You made the decision. We just presented the options.”

This is not bad faith. This is attorneys operating rationally in a system that penalizes the most valuable thing they could do: give an honest assessment of whether a patent is worth filing.


The Structural Misalignment Nobody Talks About

Even well-intentioned attorneys operate without information to improve.3

A patent filed today will not be tested — in litigation, licensing, or a sale — for five, ten, or fifteen years. Only then does someone critically evaluate every word. A feedback loop of a decade or more does not help attorneys improve. It makes them more set in their ways.

If the attorney worked on a competitor’s patents, they have been exposed to the competitor’s most valuable trade secrets. Either they cannot share what they learned — making their “experience” useless — or they share it and compromise integrity. Under 37 CFR 1.56, everyone prosecuting a patent must disclose information material to patentability, including prior art they are personally aware of.

If the attorney takes stock in the client to “align incentives,” they must recuse from conversations where the CEO needs them most. Equity ownership creates a financial interest in the outcome — and at the exact moment the CEO needs dispassionate advice, the attorney must step out of the room.

These are not edge cases. These are the structural features of the patent system working as designed.


The Hidden Cost of Nobody

When nobody fills the strategic IP role, the company forces the attorney to do two jobs: legal execution and strategic direction. The attorney is not trained for the second, not incentivized to do it well, and cannot do it inside attorney-client constraints.4

The Cost Paradox: a patent costs $50,000 when the attorney extracts the invention, educates the client, and chases decisions. The same patent costs $30,000 when a CIPO delivers a clean disclosure, a written claims strategy, and timely decisions.

The attorney did not change. The client did.

Companies without a CIPO resent their attorneys for being slow and expensive. Companies with a CIPO value the same attorneys as focused executors doing their best work.

The difference is not the attorney. It is the system the attorney operates within.


The Six Diagnostic Questions

You do not need to hire anyone to find out whether this function exists in your company. Thirty minutes, your patent portfolio, and honest answers.1

  1. Invention selection: What percentage of proposed inventions are redirected or deferred? If the answer is zero, nobody is evaluating.
  2. Prosecution strategy: Does every approved invention receive a written prosecution strategy before drafting begins? If outside counsel drafts without a playbook, they are making strategic decisions by default.
  3. Quality review: How often is work sent back to outside counsel for revision? If the answer is never, nobody is checking.
  4. Portfolio pruning: When was a patent last deliberately abandoned? Companies that never abandon are paying maintenance on dead assets.
  5. Budget alignment: What percentage of the patent budget goes to enforceable inventions? Without a process, typically 10–20%. With a CIPO, 70–80%.
  6. Independence: Does the person making IP decisions have authority independent of outside counsel? If they have never overridden a counsel recommendation, the authority is not real.

One or two gaps: targeted fixes can help.

Five or six gaps: the function does not exist. Patents are being filed by default. The cost compounds with every filing.


The Role That Separates the Two Patent Worlds

The hard questions about patents are not legal questions. They are business questions. What to patent. Who the infringer is. How to prove it. Whether the investment makes business sense.

The CEO must lead them — but the CEO does not need to become a patent expert. The CEO needs to ensure that patent expertise — real, strategic, business-aligned expertise — exists somewhere in the organization and is accountable for results.

That is the function a Chief IP Officer performs. Not by replacing the attorney — by making the attorney’s best work possible. Not by filing more patents — by ensuring that every patent filed serves a real business purpose.

Because the attorney’s incentives will not change. The CTO’s metrics will not change.

The only thing that changes the outcome is having someone in the system whose job is to connect business strategy to patent execution — and who is measured on the quality of the result.


1 Why patent competence is a CEO-level responsibility — not delegable to the CTO or outside counsel — is covered in Why Patent Competence Is a C-Suite Responsibility.

2 The structural dynamics between attorneys and clients — including malpractice liability asymmetry and why attorneys always recommend filing — are explored in Your Patent Attorney Is NOT Giving Business Advice.

3 The zero-feedback problem — how patent quality remains invisible for years until litigation or licensing forces scrutiny — is covered in The Ugly Truth — Most Patents Are Worthless.

4 The structural gap between business strategy and patent execution — and the five functions required to bridge it — is covered in The Role Nobody Fills in Investing in Patents.

5 The emotional bond between inventors and attorneys — and why that bond prevents objective evaluation of patent quality — is explored in Your Inventor Loves Your Patent Attorney. That Is the Problem.